Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS)

CNY 45.97

(0.0%)

Total Assets Summary of Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'s latest annual total assets in 2023 was 1.86 Billion CNY , up 27.33% from previous year.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'s latest quarterly total assets in 2024 Q3 was 2.07 Billion CNY , up 9.32% from previous quarter.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported annual total assets of 1.46 Billion CNY in 2022, up 17.74% from previous year.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported annual total assets of 1.24 Billion CNY in 2021, up 222.89% from previous year.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported quarterly total assets of 1.98 Billion CNY for 2024 Q1, up 6.58% from previous quarter.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported quarterly total assets of 1.9 Billion CNY for 2024 Q2, down -4.26% from previous quarter.

Annual Total Assets Chart of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (2023 - 2017)

Historical Annual Total Assets of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (2023 - 2017)

Year Total Assets Total Assets Growth
2023 1.86 Billion CNY 27.33%
2022 1.46 Billion CNY 17.74%
2021 1.24 Billion CNY 222.89%
2020 384.85 Million CNY 34.79%
2019 285.51 Million CNY 41.7%
2018 201.49 Million CNY 83.06%
2017 110.07 Million CNY 0.0%

Peer Total Assets Comparison of Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Name Total Assets Total Assets Difference
Shanghai Haoyuan Chemexpress Co., Ltd. 4.19 Billion CNY 55.56%
Hubei Jumpcan Pharmaceutical Co., Ltd. 18.14 Billion CNY 89.732%
Yabao Pharmaceutical Group Co., Ltd 3.85 Billion CNY 51.656%
Shandong Lukang Pharmaceutical Co.,Ltd. 8.8 Billion CNY 78.835%
Zhejiang Huahai Pharmaceutical Co., Ltd. 18.59 Billion CNY 89.984%
Tasly Pharmaceutical Group Co., Ltd 16.71 Billion CNY 88.854%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 10.23 Billion CNY 81.789%
Lionco Pharmaceutical Group Co.,Ltd. 1.62 Billion CNY -14.678%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 2.17 Billion CNY 14.158%
China Animal Husbandry Industry Co., Ltd. 8.94 Billion CNY 79.176%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 7.11 Billion CNY 73.824%
Zhejiang Shengda Bio-Pharm Co., Ltd. 1.71 Billion CNY -8.366%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 6.14 Billion CNY 69.67%
Henan Lingrui Pharmaceutical Co., Ltd. 4.77 Billion CNY 60.959%
Guizhou Yibai Pharmaceutical Co., Ltd. 4.78 Billion CNY 61.028%
Zhongzhu Healthcare Holding Co.,Ltd 3.01 Billion CNY 38.286%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 2.87 Billion CNY 35.237%
Jianmin Pharmaceutical Group Co.,Ltd. 4.16 Billion CNY 55.301%
North China Pharmaceutical Company Ltd. 20.95 Billion CNY 91.11%
CanSino Biologics Inc. 9.36 Billion CNY 80.116%
Zhejiang Hisun Pharmaceutical Co., Ltd. 17.61 Billion CNY 89.423%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 12.46 Billion CNY 85.055%
ChengDu ShengNuo Biotec Co.,Ltd. 1.31 Billion CNY -41.596%
Dali Pharmaceuticalco.,Ltd 473.83 Million CNY -293.18%
Harbin Pharmaceutical Group Co., Ltd. 14.11 Billion CNY 86.798%
Zhejiang Medicine Co., Ltd. 12.77 Billion CNY 85.422%
HPGC Renmintongtai Pharmaceutical Corporation 7.42 Billion CNY 74.914%
Humanwell Healthcare (Group) Co.,Ltd. 36.2 Billion CNY 94.854%
Ginwa Enterprise (Group) Inc. 2.1 Billion CNY 11.645%
KPC Pharmaceuticals, Inc. 9.59 Billion CNY 80.576%
Changchun BCHT Biotechnology Co. 5.04 Billion CNY 63.081%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 2.2 Billion CNY 15.688%
Ningbo Menovo Pharmaceutical Co., Ltd. 4.42 Billion CNY 57.884%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 10.85 Billion CNY 82.832%
Nanjing Well Pharmaceutical Group Co.,Ltd. 2.27 Billion CNY 18.249%
Joincare Pharmaceutical Group Industry Co.,Ltd. 36.35 Billion CNY 94.876%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 15.49 Billion CNY 87.978%
Chongqing Taiji Industry(Group) Co.,Ltd 14.41 Billion CNY 87.073%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 78.58 Billion CNY 97.629%
China National Medicines Corporation Ltd. 32.45 Billion CNY 94.259%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 1.89 Billion CNY 1.572%
Shenzhen Chipscreen Biosciences Co., Ltd. 3.2 Billion CNY 41.84%
Beijing Tongrentang Co., Ltd 30.08 Billion CNY 93.808%
Tibet Weixinkang Medicine Co., Ltd. 1.77 Billion CNY -4.847%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 114.03 Billion CNY 98.366%
Hunan Fangsheng Pharmaceutical Co., Ltd. 3.08 Billion CNY 39.532%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 11.66 Billion CNY 84.03%
Shanghai Jiaoda Onlly Co.,Ltd 815.09 Million CNY -128.565%
Jiang Zhong Pharmaceutical Co.,Ltd 6.12 Billion CNY 69.601%
Guobang Pharma Ltd. 10.36 Billion CNY 82.02%
Mayinglong Pharmaceutical Group Co., LTD. 4.82 Billion CNY 61.424%
Cisen Pharmaceutical Co., Ltd. 7.33 Billion CNY 74.611%
Hunan Warrant Pharmaceutical Co.,Ltd 2.17 Billion CNY 14.42%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 2.05 Billion CNY 9.197%
Shandong Buchang Pharmaceuticals Co., Ltd. 20.89 Billion CNY 91.083%
Zhejiang Starry Pharmaceutical Co.,Ltd. 5.51 Billion CNY 66.243%
Kangmei Pharmaceutical Co., Ltd. 14.28 Billion CNY 86.954%
Henan Taloph Pharmaceutical Stock Co.,Ltd 3.57 Billion CNY 47.915%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 4.67 Billion CNY 60.165%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 9.52 Billion CNY 80.439%
Shanghai Shyndec Pharmaceutical Co., Ltd. 19.35 Billion CNY 90.373%
Shanghai Yizhong Pharmaceutical Co., Ltd. 1.57 Billion CNY -18.41%
Tibet Rhodiola Pharmaceutical Holding Co. 4.58 Billion CNY 59.388%
Sichuan Huiyu Pharmaceutical Co., Ltd. 4.68 Billion CNY 60.24%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 2.85 Billion CNY 34.761%